![Biomedicines | Free Full-Text | Long-Term Exposure to Temozolomide Affects Locomotor Activity and Cartilage Structure of Elderly Experimental Rats Biomedicines | Free Full-Text | Long-Term Exposure to Temozolomide Affects Locomotor Activity and Cartilage Structure of Elderly Experimental Rats](https://www.mdpi.com/biomedicines/biomedicines-08-00541/article_deploy/html/images/biomedicines-08-00541-g001.png)
Biomedicines | Free Full-Text | Long-Term Exposure to Temozolomide Affects Locomotor Activity and Cartilage Structure of Elderly Experimental Rats
![Patient-Tailored, Imaging-Guided, Long-Term Temozolomide Chemotherapy in Patients with Glioblastoma - Norbert Galldiks, Lutz W. Kracht, Lothar Burghaus, Roland T. Ullrich, Heiko Backes, Anna Brunn, Wolf-Dieter Heiss, Andreas H. Jacobs, 2010 Patient-Tailored, Imaging-Guided, Long-Term Temozolomide Chemotherapy in Patients with Glioblastoma - Norbert Galldiks, Lutz W. Kracht, Lothar Burghaus, Roland T. Ullrich, Heiko Backes, Anna Brunn, Wolf-Dieter Heiss, Andreas H. Jacobs, 2010](https://journals.sagepub.com/cms/10.2310/7290.2010.00002/asset/images/large/10.2310_7290.2010.00002-fig3.jpeg)
Patient-Tailored, Imaging-Guided, Long-Term Temozolomide Chemotherapy in Patients with Glioblastoma - Norbert Galldiks, Lutz W. Kracht, Lothar Burghaus, Roland T. Ullrich, Heiko Backes, Anna Brunn, Wolf-Dieter Heiss, Andreas H. Jacobs, 2010
Nano-Codelivery of Temozolomide and siPD-L1 to Reprogram the Drug-Resistant and Immunosuppressive Microenvironment in Orthotopic Glioblastoma | ACS Nano
![Cognitive Function Remains Stable Following Concurrent Temozolomide-based Chemoradiation Therapy in Low-Grade Gliomas – Consult QD Cognitive Function Remains Stable Following Concurrent Temozolomide-based Chemoradiation Therapy in Low-Grade Gliomas – Consult QD](https://consultqd.clevelandclinic.org/wp-content/uploads/sites/2/2021/10/21-CNR-2409162-CQD-650x450-1-650x450.jpg)
Cognitive Function Remains Stable Following Concurrent Temozolomide-based Chemoradiation Therapy in Low-Grade Gliomas – Consult QD
![Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers - ScienceDirect Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0939641121002150-ga1.jpg)
Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers - ScienceDirect
![Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling | British Journal of Cancer Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2017.89/MediaObjects/41416_2017_Article_BFbjc201789_Fig1_HTML.jpg)
Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling | British Journal of Cancer
![IJMS | Free Full-Text | Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells IJMS | Free Full-Text | Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells](https://www.mdpi.com/ijms/ijms-23-05238/article_deploy/html/images/ijms-23-05238-g004.png)
IJMS | Free Full-Text | Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells
![Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial - eClinicalMedicine Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial - eClinicalMedicine](https://www.thelancet.com/cms/asset/52ea043e-9109-4396-adf1-8013da94b295/gr1.jpg)
Mebendazole plus lomustine or temozolomide in patients with recurrent glioblastoma: A randomised open-label phase II trial - eClinicalMedicine
![Novel Imidazotetrazine Evades Known Resistance Mechanisms and Is Effective against Temozolomide-Resistant Brain Cancer in Cell Culture | ACS Chemical Biology Novel Imidazotetrazine Evades Known Resistance Mechanisms and Is Effective against Temozolomide-Resistant Brain Cancer in Cell Culture | ACS Chemical Biology](https://pubs.acs.org/cms/10.1021/acschembio.2c00022/asset/images/large/cb2c00022_0009.jpeg)
Novel Imidazotetrazine Evades Known Resistance Mechanisms and Is Effective against Temozolomide-Resistant Brain Cancer in Cell Culture | ACS Chemical Biology
![Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival | BMC Neurology | Full Text Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival | BMC Neurology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12883-021-02461-9/MediaObjects/12883_2021_2461_Fig2_HTML.png)
Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival | BMC Neurology | Full Text
![IJMS | Free Full-Text | Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells IJMS | Free Full-Text | Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells](https://www.mdpi.com/ijms/ijms-23-05238/article_deploy/html/images/ijms-23-05238-g001.png)
IJMS | Free Full-Text | Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells
![PDF] Efficacy of concomitant and adjuvant temozolomide in glioblastoma treatment. A multicentre randomized study. | Semantic Scholar PDF] Efficacy of concomitant and adjuvant temozolomide in glioblastoma treatment. A multicentre randomized study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/74dc080ed9ffe0010ba91635bae4f38cfea290a3/3-Figure1-1.png)
PDF] Efficacy of concomitant and adjuvant temozolomide in glioblastoma treatment. A multicentre randomized study. | Semantic Scholar
![Long-term temozolomide might be an optimal choice for patient with multifocal glioblastoma, especially with deep-seated structure involvement: a case report and literature review – topic of research paper in Clinical medicine. Download Long-term temozolomide might be an optimal choice for patient with multifocal glioblastoma, especially with deep-seated structure involvement: a case report and literature review – topic of research paper in Clinical medicine. Download](https://cyberleninka.org/viewer_images/19149/f/1.png)
Long-term temozolomide might be an optimal choice for patient with multifocal glioblastoma, especially with deep-seated structure involvement: a case report and literature review – topic of research paper in Clinical medicine. Download
![IJMS | Free Full-Text | Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells IJMS | Free Full-Text | Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells](https://pub.mdpi-res.com/ijms/ijms-23-05238/article_deploy/html/images/ijms-23-05238-g002.png?1652254487)
IJMS | Free Full-Text | Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells
![Prolonged Administration of Temozolomide in Adult Patients with Anaplastic Glioma | Anticancer Research Prolonged Administration of Temozolomide in Adult Patients with Anaplastic Glioma | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/31/11/3873/F2.large.jpg)
Prolonged Administration of Temozolomide in Adult Patients with Anaplastic Glioma | Anticancer Research
![IJMS | Free Full-Text | Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells IJMS | Free Full-Text | Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells](https://pub.mdpi-res.com/ijms/ijms-23-05238/article_deploy/html/images/ijms-23-05238-g006.png?1652254483)
IJMS | Free Full-Text | Effects of Long-Term Temozolomide Treatment on Glioblastoma and Astrocytoma WHO Grade 4 Stem-like Cells
![Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles in: Neurosurgical Focus Volume 37 Issue 6 (2014) Journals Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles in: Neurosurgical Focus Volume 37 Issue 6 (2014) Journals](https://thejns.org/focus/cover/covers/neurosurg-focus-37-6_cover.jpg)